Stock Report

Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore

Posted On : 2026-07-24 20:48:16( TIMEZONE : IST )

Neogen Chemicals Limited (CIN: L24200MH1989PLC050919) has disclosed its unaudited consolidated financial results for the first quarter ended June 30, 2026 (Q1 FY27).

The company posted a strong performance across both top-line and bottom-line parameters, driven by robust operational revenue expansion and an expansion in operating margins compared to previous periods.

Top-Line Growth and Revenue Performance

Note: All financial figures are as reported in ₹ Crore in the company's official financial statements.

Revenue from Operations: Stood at ₹250.29 crore in Q1 FY27, marking a 34.04% year-on-year (YoY) increase compared to ₹186.73 crore recorded in the corresponding quarter of the previous fiscal (Q1 FY26). On a quarter-on-quarter (QoQ) basis, operational revenue grew by 1.51% from ₹246.56 crore in Q4 FY26.

Other Income: Recorded at ₹3.86 crore during the quarter under review, up from ₹1.18 crore in Q1 FY26 and ₹0.98 crore in Q4 FY26.

Total Income: Reached ₹254.15 crore for Q1 FY27, representing a 35.25% YoY growth over ₹187.91 crore in Q1 FY26 and a 2.67% QoQ gain from ₹247.54 crore in Q4 FY26.

Profitability and Margin Expansion

Profit Before Tax (PBT): Expanded 62.91% YoY to ₹23.28 crore in Q1 FY27, up from ₹14.29 crore in Q1 FY26. Sequentially, PBT grew 46.88% QoQ from ₹15.85 crore in Q4 FY26.

Share of Profit of Associates / Joint Venture: Contributed ₹0.20 crore to total income before tax in Q1 FY27, compared to ₹0.05 crore in Q1 FY26.

Tax Expenses: Totaled ₹6.17 crore for the quarter, which included current tax of ₹6.03 crore and deferred tax of ₹0.14 crore (versus total tax expenses of ₹4.03 crore in Q1 FY26).

Net Profit After Tax (PAT): Surged 66.76% YoY to ₹17.11 crore, compared to ₹10.26 crore in Q1 FY26. Sequentially, net profit rose 50.22% QoQ from ₹11.39 crore in Q4 FY26.

Total Comprehensive Income: Stood at ₹17.28 crore (including net other comprehensive income of ₹0.17 crore), up from ₹10.15 crore in Q1 FY26 and ₹12.34 crore in Q4 FY26.

Earnings Per Share (EPS): Basic and Diluted EPS for the quarter increased to ₹6.29 per share (face value ₹10 per share, not annualized), up from ₹3.89 in Q1 FY26 and ₹4.32 in Q4 FY26.

Operating Margin: Expanded to 19.35% for Q1 FY27, up from 17.82% reported in Q4 FY26.

Breakdown of Quarterly Expenses

Total consolidated expenses for Q1 FY27 came in at ₹231.07 crore, representing an increase of 33.05% YoY compared to ₹173.67 crore in Q1 FY26, while remaining nearly flat compared to ₹231.72 crore in Q4 FY26. Key cost items include:

Cost of Materials Consumed: Stood at ₹180.03 crore (up from ₹128.38 crore in Q1 FY26).

Purchase of Traded Goods: Reported at ₹0.74 crore (versus Nil in Q1 FY26).

Changes in Inventories: Stood at -₹47.00 crore (versus -₹26.63 crore in Q1 FY26).

Employee Benefits Expenses: Rose to ₹25.30 crore (compared to ₹19.57 crore in Q1 FY26 and ₹20.20 crore in Q4 FY26).

Finance Costs: Stood at ₹20.81 crore (versus ₹12.67 crore in Q1 FY26 and ₹21.47 crore in Q4 FY26).

Depreciation and Amortization Expenses: Increased to ₹8.20 crore (up from ₹5.78 crore in Q1 FY26).

Other Expenses: Totaled ₹42.99 crore (versus ₹33.90 crore in Q1 FY26 and ₹45.65 crore in Q4 FY26).

Balance Sheet Position and Key Financial Ratios

Net Worth: Increased significantly to ₹984.47 crore as of June 30, 2026, up from ₹805.90 crore as of March 31, 2026.

Debt Equity Ratio: Improved to 1.40 times as of June 30, 2026, compared to 1.63 times as of March 31, 2026.

Debt Service Coverage Ratio (DSCR): Stood at 1.55 times for the quarter (1.17 times on a trailing twelve-month basis), improving from 1.25 times in Q4 FY26.

Interest Service Coverage Ratio (ISCR): Stood at 2.51 times for the quarter (1.96 times on a trailing twelve-month basis), up from 2.09 times in Q4 FY26.

Current Ratio: Stood at 1.26 times as of June 30, 2026 (compared to 1.27 times as of March 31, 2026).

Long-Term Debt to Working Capital: Stood at 3.19 times (versus 3.07 times in Q4 FY26).

Total Debts to Total Assets: Decreased to 0.43 times (versus 0.46 times as of March 31, 2026).

Current Liability Ratio: Recorded at 0.52 times (versus 0.53 times in Q4 FY26).

Debtors Turnover: Stood at 130 days (annualized), compared to 129 days as of March 31, 2026.

Inventory Turnover: Stood at 226 days (annualized), compared to 201 days as of March 31, 2026.

Capital Structure

Paid-Up Equity Share Capital: Expanded to ₹27.38 crore (comprising equity shares with a face value of ₹10 each), up from ₹26.38 crore recorded as of March 31, 2026.

Other Equity: Stood at ₹789.87 crore as of June 30, 2026.

Shares of Neogen Chemicals Limited was last trading in BSE at Rs. 2063.35 as compared to the previous close of Rs. 2086.90. The total number of shares traded during the day was 2074 in over 377 trades.

The stock hit an intraday high of Rs. 2105.40 and intraday low of 2030.80. The net turnover during the day was Rs. 4281711.00.